Mechanisms of Tumor-Induced Immunosuppression: Evidence for Contact-Dependent T Cell Suppression by Monocytes

Molecular Medicine

Volumn 2, Issue 6, 1996, Pages 692-701

  Jaffe, Michele L ^a   Arai, Hiroshi ^a   Nabel, Gary J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD11B ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; COLON CARCINOGENESIS; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FLUORESCENCE ACTIVATED CELL SORTER; LYMPHOCYTE PROLIFERATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TUMOR GROWTH; TUMOR IMMUNOLOGY;

ANIMALS; ANTIGENS, CD11; CELL DIVISION; CONTACT INHIBITION; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOSUPPRESSION; MICE; MICE, INBRED BALB C; MONOCYTES; NEOPLASMS, EXPERIMENTAL; SPLEEN; T-LYMPHOCYTES;

EID: 0030465813     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401653     Document Type: Article

References (23)

1. Broder S, Waldmann TA. (1978) The suppressor network in cancer. N. Engl. J. Med. 299: 1281-1284.
2. Deckers PJ, Davis RC, Parker GA, Mannick JA. (1973) The effect of tumor size on concomitant tumor immunity. Cancer Res. 33: 139.
3. Maccubbin DL, Mace KF, Ehrke MJ, Mihich E. (1989) Modification of host antitumor defense mechanisms in mice by progressively growing tumor. Cancer Res. 49: 4216-4224.
4. North RJ, Bursuker I. (1984) Generation and decay of the immune response to a progressive fibrosarcoma. J. Exp. Med. 159: 1312-1321.
5. Janeway CA, Golstein P. (1993) Lymphocyte activation and effector functions. Curr. Opin. Immunol. 5: 313-323.
6. Weiss A. (1993) T cell antigen receptor signal transduction: A tale of tails and cytoplasmic protein-tyrosine kinases. Cell 73: 209-212.
7. Weiss A, Littman DR. (1994) Signal transduction by lymphocyte antigen receptors. Cell 76: 263-274.
8. Tada T, Ohzeki S, Utsumi K, et al. (1991) Transforming growth factor-β-induced inhibition of T cell function. J. Immunol. 146: 1077-1082.
9. Young RM, Wright MA, Coogan M, Young ME, Bagash J. (1992) Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor β. Cancer Immunol. Immunother. 35: 14-18.
10. Malick AP, Garner R, Black SP, Elgert KD. (1984) Normal and tumor-bearing host macrophage factor-mediated modulation of mixed-lymphocyte reaction responsiveness: Separation of T-lymphocyte subset susceptibility to enhancing and inhibitory factors. Cell. Immunol. 85: 11.
11. Walker TM, Burger CJ, Elgert KD. (1994) Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: Partial dysregulation through interleukin-10. Cell. Immunol. 154: 342-357.
12. Fu Y, Watson G, Jimenez JJ, Wang Y, Lopez DM. (1990) Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Cancer Res. 50: 227-234.
13. 2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. J. Leukoc. Biol. 44: 474-484.
14. Watson GA, Fu Y, Lopez DM. (1991 ) Splenic macrophages from tumor-bearing mice coexpressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms. J. Leukoc. Biol. 49: 126-138.
15. Aoe T, Okamoto Y, Saito T. (1995) Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J. Exp. Med. 181: 1881-1886.
16. Plautz GE, Yang Z, Wu B, Gao X, Huang L, Nabel GJ. (1993) Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci. U.S.A. 90: 4645-4649.
17. Fernandez-Cruz E, Gilman SC, Feldman JD. (1982) Altered levels of mononuclear leukocytes in tumor-bearing rats: decrease of helper T lymphocytes and increase of suppressor cells. J. Immunol. 129: 1324-1328.
18. Mizoguchi H, O'Shea JJ, Longo DL, Loeffler CM, McVicar DW, Ochoa AC. (1992) Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258: 1795-1798.
19. Smith DR, Kunkel SL, Burdick MD, et al. (1994) Production of interleukin-10 by human bronchogenic carcinoma. Am. J. Pathol. 145: 18-25.
20. Howard M, O'Garra A. (1992) Biological properties of interleukin 10. Immunol. Today 13: 198-200.
21. Ko-Huang L, Lauener RP, Winchester RJ, Geha RS, Vercelli D. (1991) Engagement of CD14 on human monocytes terminates T cell proliferation by delivering a negative signal to T cells. J. Immunol. 147: 1134-1138.
22. Stach RM, Rowley DA. (1993) A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor β and suppresses cytolytic T cell responses to unrelated alloantigens. J. Exp. Med. 178: 841-852.
23. Denham S, Rowland IJ. (1992) Inhibition of the reactive proliferation of lymphocytes by activated macrophages: The role of nitric oxide. Clin. Exp. Immunol. 87: 157-162.